Iv Stabilizer
Product Images NDC 73380-4715

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Iv Stabilizer (NDC 73380-4715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Innate Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Lumoxiti 01)

IV STABILIZER Lumoxit injection vial label featuring the active ingredient moxetumomab pasudotox-tdfk. The label specifies use for intravenous infusion only, after reconstitution and dilution. The product is labeled by Innate Pharma, Inc.*

FDA Label Image

Figure (Lumoxiti 02)

Packaging label of IV STABILIZER by Innate Pharma, Inc. The label reads 'IV Solution Stabilizer for LUMOXIT®' and includes a prominent red warning 'NOT FOR DIRECT RECONSTITUTION OF LUMOXIT®.' The product is presented in a clear vial with a gray cap.*

FDA Label Image

Figure (Lumoxiti 03)

Packaging label of LUMOXIT (moxetumomab pasudotox-tdfk) injection for intravenous infusion only, after reconstitution and dilution. The vial is clear with a blue cap and labeled with the proprietary name LUMOXIT, active ingredient, and administration instructions. It is labeled by Innate Pharma, Inc.*

FDA Label Image

Figure (Lumoxiti 04)

IV STABILIZER container labeled as Sterile Water for Injection, USP. The image shows a clear vial with a gray cap, containing sterile water intended for injection. The label prominently displays the text 'Sterile Water for Inj., USP'. The product is from Innate Pharma, Inc.*

FDA Label Image

Figure (Lumoxiti 05)

IV STABILIZER injection vial labeled LUMOXITI (moxetumomab pasudotox-tdfk) for intravenous infusion only, with instructions for use after reconstitution and dilution. The image also shows a syringe inserted into the vial's rubber stopper. The label indicates the product is for infusion and provides administration guidance. Labeler: Innate Pharma, Inc.*

FDA Label Image

Figure (Lumoxiti 06)

The image shows a clear glass vial labeled IV Solution Stabilizer for LUMOXITI®. The label includes a prominent warning in red text stating, 'NOT FOR DIRECT RECONSTITUTION OF LUMOXITI®.' The vial has a gray cap and is associated with the labeler Innate Pharma, Inc.*

FDA Label Image

Figure (Lumoxiti 07)

IV STABILIZER 0.9% Sodium Chloride Injection, USP 50 mL bag from Innate Pharma, Inc. The image shows a clear plastic IV bag with two ports at the bottom and labeling indicating the product strength and volume.*

FDA Label Image

Principal Display Panel (1 mg Vial Carton)

Packaging label for Lumoxiti 1 mg/vial (moxetumomab pasudotox-tdfk) for injection. The label includes instructions for use with IV Solution Stabilizer, cautions for pharmacists, and notes that the vial is single-dose with no preservatives. Innate Pharma, Inc. is indicated as the manufacturer. The label also shows the product NDC 73380-4700-1.*

FDA Label Image

Principal Display Panel (1 mL Vial Carton)

Packaging label for IV Solution Stabilizer for LUMOXITI, 1 mL single-dose vial, by Innate Pharma, Inc. The label includes usage instructions specifically for pharmacists to prepare infusion bags prior to adding LUMOXITI. The label emphasizes not to use this product to reconstitute LUMOXITI vials and includes storage instructions, tamper-evident label markings, barcode, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.